Nurix Therapeutics NRIX - Options Chain | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Nurix Therapeutics Inc (NRIX)
Nurix Therapeutics Inc (NRIX) Options

Nurix Therapeutics Inc (NRIX)

18.24

-1.27

(-6.51%)

Closed 11 January 8:00AM

Delayed by 15 minutes

18.24

0.02

(0.11%)

After Hours: 10:10AM

Delayed by 15 minutes

NRIX Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	14.10	17.00	20.30	15.55	0.00	0.00 %	0	0	-
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
10.00	6.90	9.60	0.00	8.25	0.00	0.00 %	0	0	-
12.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
15.00	1.30	4.40	0.00	2.85	0.00	0.00 %	0	0	-
17.50	0.45	2.00	3.23	1.225	0.00	0.00 %	0	6	-
20.00	0.50	1.00	0.50	0.75	-1.55	-75.61 %	4	3,115	11/1/2025
22.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
25.00	0.76	0.80	0.76	0.78	0.00	0.00 %	0	52	-
30.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
35.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
12.50	0.15	0.40	0.15	0.275	0.00	0.00 %	0	31	-
15.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
17.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
20.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
22.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
25.00	5.40	7.80	4.85	6.60	0.00	0.00 %	0	8	-
30.00	10.70	13.70	4.50	12.20	0.00	0.00 %	0	0	-
35.00	16.00	18.80	0.00	17.40	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
VRMEVerifyMe Inc	US$ 2.57 (52.98%)	57.83M
WKEYWISeKey International Holdings AG	US$ 10.041 (52.83%)	6.72M
DATSDatChat Inc	US$ 4.8105 (49.86%)	158.65M
CDTConduit Pharmaceuticals Inc	US$ 0.1214 (48.05%)	1.17B
INTZIntrusion Inc	US$ 2.8888 (44.44%)	40.61M
IGMSIGM Biosciences Inc	US$ 2.095 (-66.21%)	5.81M
CDTGCDT Environmental Technology Investment Holdings Ltd	US$ 1.87 (-51.30%)	2.28M
MODVModivCare Inc	US$ 6.51 (-47.88%)	2.73M
AIFUAIX Inc	US$ 0.420501 (-47.76%)	7.85M
MRSNMersana Therapeutics Inc	US$ 0.691 (-46.85%)	58.44M
CDTConduit Pharmaceuticals Inc	US$ 0.1214 (48.05%)	1.17B
NVDANVIDIA Corporation	US$ 135.91 (-3.00%)	207.53M
RGTIRigetti Computing Inc	US$ 8.9299 (-11.06%)	178.82M
VMARVision Marine Technologies Inc	US$ 2.14 (40.79%)	175.57M
DATSDatChat Inc	US$ 4.8105 (49.86%)	158.65M

Monksdream

Monksdream 3 months ago

NRIX 10Q due Oct 17

Monksdream

Monksdream 3 months ago

NRIX 10 Q due 10 October

Monksdream

Monksdream 4 months ago

NRIX creeping higher

Monksdream

Monksdream 6 months ago

NRIX 10 Q expected JULY11

Monksdream

Monksdream 7 months ago

NRIX new 52 week high

Monksdream

Monksdream 7 months ago

NRIX more new highs up ahead

Monksdream

Monksdream 9 months ago

Monksdream

Monksdream 9 months ago

Monksdream

Monksdream 10 months ago

NRIX new 52 week high

TheFinalCD

TheFinalCD 2 years ago

https://ih.advfn.com/stock-market/NASDAQ/nurix-therapeutics-NRIX/stock-news/88898489/cathie-wood-doubles-down-on-these-2-strong-buy

infamous

infamous 4 years ago

what the F is wrong with this fkn stock? does it ever go up???

Phosphene

Phosphene 4 years ago

CEO: Dr. Arthur T. Sands

https://www.nurixtx.com/arthur-t-sands-m-d-ph-d/

Phosphene

Phosphene 4 years ago

Strategic partnerships with Sanofi and Gilead Sciences Inc.

https://www.nurixtx.com/research-development/strategic-partnerships/

Wellington and Baker Brothers are among Institutional Ownership and Shareholders:

https://fintel.io/so/us/nrix?__cf_chl_jschl_tk__=c9a7439112376e9f70de91c1316dfcc7e26d3519-1607403189-0-AT-0XpHMlNGWmcEzimwDKelDxLnOK6gsd8IihalGD8DcDe76KQlrWnh2Q1G3OLjfsidXSQyjVOkcCg3lXIXgKu6RIlw8DMusjRJpgnTzQP2qkahd1WSCP-5At2BI9Udfzc2vqpmlZOV3prAMIdFIh1_urJuBNq7hGlM4oSEJKFEFs8WDerUagukeDe9yBmvVg0Ne17vR8ByRaN-BlyHHxPWeTerJ_ZHoD1jnsxFYInhjhkK-XNkhe3BJ0Wzq3782kDVndNMNsb1glMkmm_NlSnc8Xbwve1nF3nGShcpgUxA-nefEgd9L74SzGXF1WftTIX4HYgwtb1BRzq82RClNfm9dr9Xb-hKp3xKKiYL4k9KfqV9OAePxDJoYgKqLUziXoA

Phosphene

Phosphene 4 years ago

Data support a planned clinical trial of NX-2127 in B-cell malignancies

http://www.globenewswire.com/news-release/2020/12/07/2140737/0/en/Nurix-Therapeutics-Presents-Preclinical-Data-at-62nd-American-Society-of-Hematology-ASH-Annual-Meeting-and-Exposition.html

Nurix Therapeutics

Red Rock Resorts

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions